In this video, Erika P. Hamilton, MD, discusses results from the HER2CLIMB-05 trial of tucatinib in combination with ...
In this video from ASCO Annual Meeting, Andrew J. Armstrong, MD, MS, discusses final results of the phase 2 CHAMP trial ...
Trust in the CDC has plummeted among adults since last year, although opinions were split by political party, according to a ...
Vindico Medical Education, a CME platform that delivers high-quality content for health care professionals, has partnered ...
The FDA’s approval of inebilizumab has heralded a new era for patients with IgG4-related disease, while novel agents moving ...
With roles as a clinician, professor, researcher, director and company founder, Ruchi Gupta, MD, MPH, has a lot to juggle — ...
In this video, Shimoli Barot, MD, discusses results from the phase 3 lidERA BC clinical trial, which assessed efficacy and ...
A growing body of evidence suggests sensitive skin syndrome is a distinct condition driven by impaired neurosensory and ...
The FDA approved another over-the-counter intranasal naloxone product as an emergency treatment for opioid overdoses, the ...
The examination revealed a mildly fussy baby with normal vital signs. The only other positive finding was a somewhat ...
Last year, HHS and dozens of health insurers announced an industry pledge to streamline and reduce prior ...
The FDA approved risankizumab-rzaa for children aged at least 6 years with moderate to severe plaque psoriasis who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results